| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.002 | 0.959 | Cholesterol antagonist | 0.952 0.001 DBMET00518 0.959 0.001 DBMET00599 | DBMET00599 | |
| 0.866 | 0.001 | 0.906 | Androgen agonist | 0.906 0.001 DBMET00518 0.302 0.003 DBMET00599 | DBMET00518 | |
| 0.857 | 0.002 | 0.857 | Androgen antagonist | 0.501 0.004 DBMET00518 0.253 0.009 DBMET00599 | ||
| 0.837 | 0.011 | 0.938 | Transcription factor NF kappa B inhibitor | 0.714 0.019 DBMET00518 0.938 0.004 DBMET00599 | DBMET00599 | |
| 0.827 | 0.001 | 0.827 | Aromatase inhibitor | 0.723 0.002 DBMET00518 0.233 0.007 DBMET00599 | ||
| 0.829 | 0.012 | 0.884 | Antiinflammatory | 0.866 0.008 DBMET00518 0.884 0.006 DBMET00599 | DBMET00599 | |
| 0.813 | 0.015 | 0.822 | Apoptosis agonist | 0.687 0.033 DBMET00518 0.822 0.014 DBMET00599 | DBMET00599 | |
| 0.793 | 0.001 | 0.972 | Anabolic | 0.972 0 DBMET00518 0.235 0.002 DBMET00599 | DBMET00518 | |
| 0.755 | 0.003 | 0.918 | Interleukin agonist | 0.353 0.028 DBMET00518 0.918 0.002 DBMET00599 | DBMET00599 | |
| 0.754 | 0.017 | 0.799 | Caspase 9 stimulant | 0.799 0.011 DBMET00599 | DBMET00599 | |
| 0.735 | 0.001 | 0.735 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.099 0.004 DBMET00518 0.02 0.014 DBMET00599 | ||
| 0.733 | 0.004 | 0.745 | Hypoxia-inducible factor 1 alpha inhibitor | 0.494 0.015 DBMET00518 0.745 0.004 DBMET00599 | DBMET00599 | |
| 0.684 | 0.002 | 0.684 | Interleukin 2 agonist | 0.594 0.004 DBMET00518 0.647 0.003 DBMET00599 | ||
| 0.676 | 0.004 | 0.676 | Anesthetic general | 0.157 0.106 DBMET00518 0.658 0.004 DBMET00599 | ||
| 0.654 | 0.001 | 0.654 | Glucose-6-phosphate dehydrogenase inhibitor | 0.174 0.002 DBMET00518 0.12 0.002 DBMET00599 | ||
| 0.622 | 0.005 | 0.622 | Psychostimulant | 0.575 0.007 DBMET00599 | ||
| 0.605 | 0.005 | 0.767 | Diuretic | 0.767 0.003 DBMET00518 0.761 0.003 DBMET00599 | DBMET00518 | |
| 0.579 | 0.003 | 0.607 | Estrogen agonist | 0.607 0.003 DBMET00518 0.384 0.004 DBMET00599 | DBMET00518 | |
| 0.586 | 0.015 | 0.606 | Immunosuppressant | 0.528 0.026 DBMET00518 0.606 0.012 DBMET00599 | DBMET00599 | |
| 0.569 | 0.003 | 0.628 | Interferon gamma antagonist | 0.306 0.019 DBMET00518 0.628 0.002 DBMET00599 | DBMET00599 | |
| 0.564 | 0 | 0.564 | Transcortin receptor antagonist | 0.027 0.001 DBMET00518 0.017 0.001 DBMET00599 | ||
| 0.563 | 0.002 | 0.708 | Cholesterol synthesis inhibitor | 0.708 0.001 DBMET00518 0.471 0.003 DBMET00599 | DBMET00518 | |
| 0.57 | 0.013 | 0.626 | Apoptosis antagonist | 0.327 0.068 DBMET00518 0.626 0.007 DBMET00599 | DBMET00599 | |
| 0.558 | 0.012 | 0.631 | Nitric oxide antagonist | 0.435 0.022 DBMET00518 0.631 0.008 DBMET00599 | DBMET00599 | |
| 0.547 | 0.005 | 0.745 | Melanin inhibitor | 0.184 0.049 DBMET00518 0.745 0.003 DBMET00599 | DBMET00599 | |
| 0.545 | 0.027 | 0.545 | Aldehyde oxidase inhibitor | |||
| 0.521 | 0.003 | 0.521 | Lipocortins synthesis antagonist | 0.446 0.005 DBMET00518 0.43 0.007 DBMET00599 | ||
| 0.515 | 0.001 | 0.515 | RNA-directed RNA polymerase stimulant | 0.403 0.001 DBMET00518 0.325 0.002 DBMET00599 | ||
| 0.506 | 0.001 | 0.506 | 5-Alpha-reductase 2 inhibitor | 0.183 0.003 DBMET00518 0.281 0.002 DBMET00599 | ||
| 0.497 | 0.001 | 0.497 | 5-Alpha-reductase 1 inhibitor | 0.193 0.003 DBMET00518 0.163 0.003 DBMET00599 | ||
| 0.515 | 0.027 | 0.69 | Immunostimulant | 0.59 0.018 DBMET00518 0.69 0.008 DBMET00599 | DBMET00599 | |
| 0.491 | 0.004 | 0.491 | Neurotrophic factor enhancer | 0.175 0.104 DBMET00518 0.372 0.007 DBMET00599 | ||
| 0.468 | 0.001 | 0.468 | 5-Alpha-reductase inhibitor | 0.298 0.003 DBMET00518 0.37 0.002 DBMET00599 | ||
| 0.472 | 0.005 | 0.472 | Sodium/bile acid cotransporter inhibitor | 0.432 0.01 DBMET00518 0.398 0.018 DBMET00599 | ||
| 0.463 | 0.001 | 0.714 | Glycine receptor antagonist | 0.714 0 DBMET00518 0.511 0.001 DBMET00599 | DBMET00518 | |
| 0.459 | 0.003 | 0.459 | Estrogen receptor beta agonist | 0.361 0.003 DBMET00518 0.227 0.004 DBMET00599 | ||
| 0.451 | 0.004 | 0.451 | Estrogen receptor alpha antagonist | 0.099 0.028 DBMET00518 0.071 0.066 DBMET00599 | ||
| 0.455 | 0.009 | 0.599 | Hepatoprotectant | 0.427 0.011 DBMET00518 0.599 0.005 DBMET00599 | DBMET00599 | |
| 0.448 | 0.003 | 0.448 | Estrogen receptor alpha agonist | 0.255 0.004 DBMET00518 0.192 0.005 DBMET00599 | ||
| 0.438 | 0.004 | 0.438 | Estrogen antagonist | 0.206 0.012 DBMET00518 0.203 0.013 DBMET00599 | ||
| 0.432 | 0.008 | 0.662 | Amylase inhibitor | 0.662 0.003 DBMET00599 | DBMET00599 | |
| 0.451 | 0.029 | 0.457 | Caspase 3 stimulant | 0.457 0.028 DBMET00599 | DBMET00599 | |
| 0.43 | 0.009 | 0.43 | Phospholipase C inhibitor | 0.407 0.01 DBMET00518 0.21 0.038 DBMET00599 | ||
| 0.417 | 0.001 | 0.417 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.293 0.002 DBMET00518 0.124 0.007 DBMET00599 | ||
| 0.418 | 0.002 | 0.418 | Aldosterone antagonist | 0.137 0.006 DBMET00518 0.054 0.025 DBMET00599 | ||
| 0.414 | 0.003 | 0.414 | Estradiol 17 beta-dehydrogenase inhibitor | 0.084 0.013 DBMET00518 | ||
| 0.416 | 0.007 | 0.424 | NOS3 expression enhancer | 0.273 0.022 DBMET00518 0.424 0.007 DBMET00599 | DBMET00599 | |
| 0.412 | 0.005 | 0.412 | DNA polymerase I inhibitor | 0.281 0.013 DBMET00518 0.335 0.009 DBMET00599 | ||
| 0.454 | 0.065 | 0.745 | Cyclophilin D inhibitor | 0.372 0.108 DBMET00518 0.745 0.01 DBMET00599 | DBMET00599 | |
| 0.407 | 0.034 | 0.622 | Antioxidant | 0.447 0.027 DBMET00518 0.622 0.01 DBMET00599 | DBMET00599 | |
| 0.383 | 0.009 | 0.469 | Protein kinase stimulant | 0.469 0.005 DBMET00599 | DBMET00599 | |
| 0.376 | 0.005 | 0.376 | Hedgehog signaling inhibitor | 0.097 0.07 DBMET00518 0.127 0.035 DBMET00599 | ||
| 0.369 | 0.001 | 0.369 | Glycine receptor agonist | 0.22 0.004 DBMET00518 0.322 0.002 DBMET00599 | ||
| 0.396 | 0.047 | 0.432 | 5 Hydroxytryptamine release stimulant | 0.432 0.04 DBMET00599 | DBMET00599 | |
| 0.354 | 0.005 | 0.354 | Estrogen receptor beta antagonist | 0.15 0.015 DBMET00518 0.123 0.029 DBMET00599 | ||
| 0.345 | 0.003 | 0.345 | Progesterone antagonist | 0.037 0.024 DBMET00518 | ||
| 0.369 | 0.031 | 0.376 | Hypolipemic | 0.189 0.103 DBMET00518 0.376 0.03 DBMET00599 | DBMET00599 | |
| 0.338 | 0.002 | 0.338 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.059 0.008 DBMET00518 | ||
| 0.337 | 0.004 | 0.337 | Farnesoid X receptor antagonist | 0.238 0.013 DBMET00518 0.204 0.02 DBMET00599 | ||
| 0.319 | 0.007 | 0.319 | Neurotrophic factor | 0.216 0.021 DBMET00599 | ||
| 0.297 | 0.005 | 0.629 | AMP-activated protein kinase stimulant | 0.629 0.003 DBMET00599 | DBMET00599 | |
| 0.287 | 0.002 | 0.287 | Arachidonic acid antagonist | 0.244 0.007 DBMET00518 0.236 0.009 DBMET00599 | ||
| 0.305 | 0.033 | 0.46 | Platelet adhesion inhibitor | 0.4 0.011 DBMET00518 0.46 0.007 DBMET00599 | DBMET00599 | |
| 0.288 | 0.018 | 0.288 | Growth factor agonist | 0.203 0.06 DBMET00599 | ||
| 0.311 | 0.052 | 0.311 | Cardiotonic | 0.206 0.113 DBMET00599 | ||
| 0.348 | 0.088 | 0.389 | Antiobesity | 0.313 0.107 DBMET00518 0.389 0.07 DBMET00599 | DBMET00599 | |
| 0.306 | 0.047 | 0.697 | Angiogenesis stimulant | 0.669 0.005 DBMET00518 0.697 0.005 DBMET00599 | DBMET00599 | |
| 0.284 | 0.029 | 0.284 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.166 0.115 DBMET00599 | ||
| 0.322 | 0.071 | 0.481 | Immunomodulator | 0.283 0.092 DBMET00518 0.481 0.026 DBMET00599 | DBMET00599 | |
| 0.25 | 0.006 | 0.25 | ABCA1 expression enhancer | 0.14 0.02 DBMET00518 0.115 0.034 DBMET00599 | ||
| 0.252 | 0.008 | 0.258 | Microtubule formation inhibitor | 0.114 0.067 DBMET00518 0.258 0.007 DBMET00599 | DBMET00599 | |
| 0.284 | 0.045 | 0.284 | Gastrin inhibitor | 0.25 0.08 DBMET00599 | ||
| 0.29 | 0.057 | 0.49 | Tumour necrosis factor alpha release inhibitor | 0.386 0.029 DBMET00518 0.49 0.015 DBMET00599 | DBMET00599 | |
| 0.312 | 0.08 | 0.312 | Calcium channel activator | |||
| 0.254 | 0.024 | 0.254 | Bone formation stimulant | 0.179 0.042 DBMET00599 | ||
| 0.232 | 0.005 | 0.232 | Pregnane X receptor agonist | 0.196 0.012 DBMET00518 | ||
| 0.23 | 0.004 | 0.23 | Bile acid receptor antagonist | 0.186 0.005 DBMET00518 0.123 0.017 DBMET00599 | ||
| 0.229 | 0.002 | 0.229 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.035 0.01 DBMET00518 | ||
| 0.264 | 0.037 | 0.264 | P-glycoprotein inhibitor | 0.225 0.051 DBMET00599 | ||
| 0.242 | 0.029 | 0.348 | Lipid peroxidase inhibitor | 0.182 0.049 DBMET00518 0.348 0.013 DBMET00599 | DBMET00599 | |
| 0.212 | 0.002 | 0.316 | Na+ K+ transporting ATPase inhibitor | 0.199 0.002 DBMET00518 0.316 0.001 DBMET00599 | DBMET00599 | |
| 0.235 | 0.03 | 0.235 | Antipruritic | 0.131 0.121 DBMET00518 | ||
| 0.225 | 0.022 | 0.225 | Adenylate cyclase inhibitor | 0.142 0.051 DBMET00599 | ||
| 0.262 | 0.059 | 0.378 | DNA synthesis inhibitor | 0.378 0.025 DBMET00599 | DBMET00599 | |
| 0.223 | 0.024 | 0.223 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.207 | 0.011 | 0.209 | Adenylate cyclase stimulant | 0.209 0.01 DBMET00518 0.155 0.054 DBMET00599 | DBMET00518 | |
| 0.26 | 0.064 | 0.506 | Free radical scavenger | 0.158 0.136 DBMET00518 0.506 0.016 DBMET00599 | DBMET00599 | |
| 0.196 | 0.007 | 0.269 | CDC25A inhibitor | 0.269 0.004 DBMET00518 0.11 0.023 DBMET00599 | DBMET00518 | |
| 0.216 | 0.028 | 0.216 | Anesthetic local | |||
| 0.212 | 0.026 | 0.242 | Protein-tyrosine phosphatase 1B inhibitor | 0.242 0.018 DBMET00518 0.209 0.027 DBMET00599 | DBMET00518 | |
| 0.187 | 0.003 | 0.187 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.017 DBMET00518 0.176 0.003 DBMET00599 | ||
| 0.185 | 0.004 | 0.185 | Glucocorticoid antagonist | 0.108 0.005 DBMET00518 0.081 0.006 DBMET00599 | ||
| 0.181 | 0.002 | 0.21 | Estrone sulfatase inhibitor | 0.21 0.002 DBMET00518 0.113 0.004 DBMET00599 | DBMET00518 | |
| 0.21 | 0.035 | 0.318 | Interleukin 6 antagonist | 0.318 0.013 DBMET00599 | DBMET00599 | |
| 0.249 | 0.081 | 0.265 | DNA damaging | 0.265 0.072 DBMET00599 | DBMET00599 | |
| 0.301 | 0.134 | 0.624 | Antibacterial | 0.46 0.053 DBMET00518 0.624 0.016 DBMET00599 | DBMET00599 | |
| 0.242 | 0.089 | 0.242 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.185 | 0.032 | 0.185 | Aldehyde dehydrogenase inhibitor | 0.139 0.054 DBMET00599 | ||
| 0.199 | 0.047 | 0.334 | Protein-tyrosine phosphatase inhibitor | 0.334 0.014 DBMET00518 0.192 0.05 DBMET00599 | DBMET00518 | |
| 0.162 | 0.015 | 0.181 | Toll-Like receptor 4 antagonist | 0.181 0.009 DBMET00599 | DBMET00599 | |
| 0.148 | 0.005 | 0.148 | Mineralocorticoid receptor antagonist | 0.076 0.012 DBMET00518 0.056 0.024 DBMET00599 | ||
| 0.139 | 0.003 | 0.139 | Progesterone agonist | 0.063 0.004 DBMET00518 0.048 0.005 DBMET00599 | ||
| 0.15 | 0.014 | 0.15 | Keratolytic | |||
| 0.14 | 0.004 | 0.14 | Liver X receptor alpha agonist | |||
| 0.171 | 0.037 | 0.276 | Alkylator | 0.122 0.066 DBMET00518 0.276 0.014 DBMET00599 | DBMET00599 | |
| 0.131 | 0.001 | 0.131 | Hedgehog signaling activator | 0.042 0.004 DBMET00518 0.033 0.009 DBMET00599 | ||
| 0.131 | 0.002 | 0.131 | Lipocortins synthesis agonist | 0.115 0.003 DBMET00518 0.117 0.003 DBMET00599 | ||
| 0.157 | 0.03 | 0.157 | Interleukin 8 antagonist | |||
| 0.14 | 0.016 | 0.14 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.153 | 0.03 | 0.266 | Antineoplastic antibiotic | 0.137 0.034 DBMET00518 0.266 0.012 DBMET00599 | DBMET00599 | |
| 0.209 | 0.087 | 0.344 | RNA-directed DNA polymerase inhibitor | 0.344 0.025 DBMET00518 0.199 0.101 DBMET00599 | DBMET00518 | |
| 0.159 | 0.044 | 0.379 | Monophenol monooxygenase inhibitor | 0.095 0.08 DBMET00518 0.379 0.012 DBMET00599 | DBMET00599 | |
| 0.133 | 0.02 | 0.133 | Inducible nitric-oxide synthase inhibitor | 0.13 0.021 DBMET00518 | ||
| 0.155 | 0.044 | 0.349 | Cyclooxygenase 3 inhibitor | 0.349 0.005 DBMET00599 | DBMET00599 | |
| 0.148 | 0.047 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.146 0.054 DBMET00599 | ||
| 0.123 | 0.024 | 0.192 | Transcription factor NF kappa B stimulant | 0.192 0.01 DBMET00599 | DBMET00599 | |
| 0.105 | 0.007 | 0.105 | Liver X receptor agonist | 0.047 0.026 DBMET00518 | ||
| 0.101 | 0.004 | 0.101 | Pregnane X receptor antagonist | |||
| 0.109 | 0.016 | 0.109 | Estrogen-related receptor beta agonist | |||
| 0.105 | 0.014 | 0.181 | GABA receptor antagonist | 0.181 0.007 DBMET00518 | DBMET00518 | |
| 0.094 | 0.004 | 0.094 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.116 | 0.029 | 0.116 | Ornithine decarboxylase inhibitor | 0.088 0.058 DBMET00599 | ||
| 0.199 | 0.113 | 0.573 | Hypoglycemic | 0.573 0.01 DBMET00599 | DBMET00599 | |
| 0.09 | 0.01 | 0.09 | Heme oxygenase stimulant | 0.07 0.025 DBMET00518 0.07 0.025 DBMET00599 | ||
| 0.104 | 0.025 | 0.104 | Lipase inhibitor | 0.089 0.034 DBMET00599 | ||
| 0.083 | 0.005 | 0.083 | Farnesoid X receptor agonist | 0.058 0.011 DBMET00518 | ||
| 0.091 | 0.013 | 0.091 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.15 | 0.075 | 0.15 | Acetylcholine M1 receptor antagonist | |||
| 0.077 | 0.002 | 0.077 | Corticosteroid-like | 0.045 0.004 DBMET00518 0.052 0.003 DBMET00599 | ||
| 0.075 | 0.003 | 0.075 | Glucocorticoid agonist | 0.053 0.004 DBMET00518 0.037 0.005 DBMET00599 | ||
| 0.114 | 0.043 | 0.114 | Prolactin inhibitor | |||
| 0.107 | 0.043 | 0.107 | Antineoplastic alkaloid | |||
| 0.185 | 0.121 | 0.375 | Peptidyltransferase inhibitor | 0.375 0.009 DBMET00599 | DBMET00599 | |
| 0.116 | 0.054 | 0.286 | Acetylcholine release stimulant | 0.286 0.004 DBMET00518 0.14 0.023 DBMET00599 | DBMET00518 | |
| 0.083 | 0.023 | 0.083 | Alcohol oxidase inhibitor | |||
| 0.142 | 0.083 | 0.266 | Insulin secretagoues | 0.266 0.017 DBMET00599 | DBMET00599 | |
| 0.069 | 0.013 | 0.069 | Adenylate cyclase 1 inhibitor | |||
| 0.075 | 0.023 | 0.109 | GABA A receptor antagonist | 0.109 0.014 DBMET00518 | DBMET00518 | |
| 0.123 | 0.074 | 0.142 | Alpha-N-acetylglucosaminidase inhibitor | 0.142 0.06 DBMET00599 | DBMET00599 | |
| 0.061 | 0.013 | 0.061 | Microtubule stabilization | 0.06 0.014 DBMET00599 | ||
| 0.059 | 0.012 | 0.059 | Parathyroid hormone antagonist | |||
| 0.05 | 0.007 | 0.05 | HMG CoA reductase inhibitor | |||
| 0.116 | 0.078 | 0.116 | Cholinergic antagonist | |||
| 0.071 | 0.034 | 0.071 | Beta tubulin antagonist | |||
| 0.086 | 0.049 | 0.086 | Acetylcholine nicotinic antagonist | |||
| 0.046 | 0.01 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET00518 0.036 0.024 DBMET00599 | ||
| 0.113 | 0.077 | 0.113 | Acetylcholine antagonist | |||
| 0.098 | 0.063 | 0.16 | UDP-glucose 4-epimerase inhibitor | 0.16 0.026 DBMET00599 | DBMET00599 | |
| 0.047 | 0.012 | 0.047 | Liver X receptor beta agonist | |||
| 0.102 | 0.067 | 0.248 | Expectorant | 0.248 0.013 DBMET00599 | DBMET00599 | |
| 0.067 | 0.037 | 0.078 | Nitric oxide donor | 0.078 0.024 DBMET00599 | DBMET00599 | |
| 0.055 | 0.025 | 0.055 | Potassium channel Kv1.3 blocker | |||
| 0.032 | 0.003 | 0.047 | Telomerase stimulant | 0.047 0.001 DBMET00599 | DBMET00599 | |
| 0.034 | 0.006 | 0.034 | Vitamin D receptor antagonist | 0.023 0.013 DBMET00599 | ||
| 0.163 | 0.139 | 0.318 | Vasodilator | 0.318 0.042 DBMET00599 | DBMET00599 | |
| 0.125 | 0.103 | 0.419 | Hemostatic | 0.332 0.013 DBMET00518 0.419 0.007 DBMET00599 | DBMET00599 | |
| 0.038 | 0.017 | 0.038 | Tubulin agonist | |||
| 0.055 | 0.035 | 0.055 | Acetylcholine M2 receptor agonist | |||
| 0.025 | 0.004 | 0.025 | Vitamin D receptor agonist | 0.016 0.013 DBMET00599 | ||
| 0.021 | 0.003 | 0.021 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.017 0.004 DBMET00518 0.014 0.006 DBMET00599 | ||
| 0.101 | 0.087 | 0.134 | Photosensitizer | 0.134 0.042 DBMET00599 | DBMET00599 | |
| 0.052 | 0.039 | 0.052 | Alpha tubulin antagonist | |||
| 0.148 | 0.136 | 0.148 | Insulin sensitizer | |||
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.079 | 0.068 | 0.079 | T cell inhibitor | 0.079 0.072 DBMET00599 | ||
| 0.025 | 0.014 | 0.025 | CYP24 inhibitor | |||
| 0.075 | 0.064 | 0.075 | Carbonic anhydrase VI inhibitor | |||
| 0.019 | 0.01 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET00599 | DBMET00599 | |
| 0.08 | 0.075 | 0.08 | Potassium channel activator | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.009 | 0.007 | 0.009 | Progesterone receptor A antagonist | |||
| 0.207 | 0.206 | 0.207 | 15-Lipoxygenase inhibitor | |||
| 0.046 | 0.045 | 0.116 | Protein 50S ribosomal subunit inhibitor | 0.116 0.01 DBMET00599 | DBMET00599 | |
| 0.08 | 0.081 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.071 DBMET00599 | DBMET00599 | |
| 0.024 | 0.034 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.008 DBMET00518 0.03 0.015 DBMET00599 | DBMET00518 | |
| 0.118 | 0.129 | 0.154 | CC chemokine 6 receptor antagonist | 0.154 0.018 DBMET00599 | DBMET00599 | |
| 0.033 | 0.046 | 0.046 | Phosphorylase inhibitor | 0.046 0.033 DBMET00599 | DBMET00599 | |
| 0.039 | 0.056 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.04 DBMET00599 | DBMET00599 | |
| 0.183 | 0.201 | 0.559 | Antithrombotic | 0.37 0.058 DBMET00518 0.559 0.021 DBMET00599 | DBMET00599 | |
| 0.105 | 0.129 | 0.306 | Thrombolytic | 0.17 0.068 DBMET00518 0.306 0.023 DBMET00599 | DBMET00599 | |
| 0.144 | 0.17 | 0.247 | Spasmolytic | 0.247 0.093 DBMET00599 | DBMET00599 | |
| 0.018 | 0.045 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 DBMET00599 | DBMET00599 | |
| 0.041 | 0.068 | 0.065 | Alpha-mannosidase inhibitor | 0.065 0.022 DBMET00599 | DBMET00599 | |
| 0.004 | 0.032 | 0.014 | Antibiotic Macrolide-like | 0.014 0.009 DBMET00599 | DBMET00599 | |
| 0.077 | 0.105 | 0.095 | Glutamate release inhibitor | 0.095 0.051 DBMET00599 | DBMET00599 | |
| 0.013 | 0.045 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET00599 | DBMET00599 | |
| 0.045 | 0.078 | 0.102 | Phosphofructokinase-1 inhibitor | 0.102 0.031 DBMET00599 | DBMET00599 | |
| 0.014 | 0.053 | 0.057 | Protein 30S ribosomal subunit inhibitor | 0.057 0.007 DBMET00599 | DBMET00599 | |
| 0.123 | 0.165 | 0.267 | Non-steroidal antiinflammatory agent | 0.267 0.036 DBMET00599 | DBMET00599 | |
| 0.066 | 0.113 | 0.1 | Triose-phosphate isomerase inhibitor | 0.1 0.047 DBMET00518 0.09 0.059 DBMET00599 | DBMET00518 | |
| 0.034 | 0.083 | 0.161 | HIV-1 integrase (Strand Transfer) inhibitor | 0.161 0.012 DBMET00518 | DBMET00518 | |
| 0.073 | 0.133 | 0.149 | Beta glucuronidase inhibitor | 0.149 0.025 DBMET00599 | DBMET00599 | |
| 0.044 | 0.106 | 0.081 | Neuraminidase (influenza) inhibitor | 0.081 0.025 DBMET00518 0.074 0.031 DBMET00599 | DBMET00518 | |
| 0.023 | 0.086 | 0.072 | Antibiotic Aminoglycoside-like | 0.072 0.005 DBMET00599 | DBMET00599 | |
| 0.024 | 0.088 | 0.05 | Mannosidase inhibitor | 0.05 0.025 DBMET00599 | DBMET00599 | |
| 0.063 | 0.128 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.059 DBMET00599 | DBMET00599 | |
| 0.153 | 0.236 | 0.29 | Vasodilator, coronary | 0.29 0.096 DBMET00599 | DBMET00599 | |
| 0.067 | 0.151 | 0.118 | Beta amyloid protein antagonist | 0.118 0.069 DBMET00599 | DBMET00599 | |
| 0.032 | 0.116 | 0.103 | Heparanase inhibitor | 0.078 0.007 DBMET00518 0.103 0.004 DBMET00599 | DBMET00599 | |
| 0.012 | 0.109 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET00599 | DBMET00599 | |
| 0.009 | 0.111 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.021 DBMET00599 | DBMET00599 | |
| 0.045 | 0.155 | 0.187 | Topoisomerase I inhibitor | 0.187 0.03 DBMET00599 | DBMET00599 | |
| 0.107 | 0.217 | 0.196 | ATPase inhibitor | 0.196 0.04 DBMET00599 | DBMET00599 | |
| 0.085 | 0.196 | 0.164 | Hexokinase inhibitor | 0.164 0.063 DBMET00599 | DBMET00599 | |
| 0.057 | 0.175 | 0.097 | Protein kinase C zeta inhibitor | 0.097 0.054 DBMET00518 | DBMET00518 | |
| 0.036 | 0.155 | 0.146 | Topoisomerase II alpha inhibitor | 0.146 0.024 DBMET00599 | DBMET00599 | |
| 0.017 | 0.14 | 0.059 | Carbonic anhydrase inhibitor | 0.059 0.047 DBMET00518 | DBMET00518 | |
| 0.049 | 0.179 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.094 0.049 DBMET00599 | DBMET00599 | |
| 0.026 | 0.165 | 0.06 | Carbonic anhydrase VA inhibitor | 0.06 0.059 DBMET00518 | DBMET00518 | |
| 0.019 | 0.162 | 0.058 | Neuraminidase inhibitor | 0.058 0.046 DBMET00599 | DBMET00599 | |
| 0.023 | 0.182 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 DBMET00518 | DBMET00518 | |
| 0.021 | 0.181 | 0.07 | Carbonic anhydrase V inhibitor | 0.07 0.043 DBMET00518 | DBMET00518 | |
| 0.121 | 0.287 | 0.463 | Angiogenesis inhibitor | 0.463 0.037 DBMET00518 0.217 0.151 DBMET00599 | DBMET00518 | |
| 0.025 | 0.193 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 DBMET00599 | DBMET00599 | |
| 0.04 | 0.21 | 0.099 | Mediator release inhibitor | 0.099 0.071 DBMET00599 | DBMET00599 | |
| 0.079 | 0.27 | 0.174 | Antiamyloidogenic | 0.174 0.12 DBMET00599 | DBMET00599 | |
| 0.012 | 0.209 | 0.055 | NMDA 2C receptor antagonist | 0.055 0.053 DBMET00518 | DBMET00518 | |
| 0.036 | 0.245 | 0.192 | Topoisomerase II inhibitor | 0.192 0.035 DBMET00599 | DBMET00599 | |
| 0.125 | 0.345 | 0.417 | Histamine release inhibitor | 0.417 0.067 DBMET00599 | DBMET00599 | |
| 0.05 | 0.292 | 0.183 | Cell adhesion inhibitor | 0.151 0.046 DBMET00518 0.183 0.03 DBMET00599 | DBMET00599 | |
| 0.053 | 0.306 | 0.182 | Cell wall synthesis inhibitor | 0.133 0.082 DBMET00518 0.182 0.038 DBMET00599 | DBMET00599 | |
| 0.008 | 0.28 | 0.231 | NMDA 2D receptor antagonist | 0.231 0.002 DBMET00518 | DBMET00518 | |
| 0.018 | 0.292 | 0.083 | NMDA receptor antagonist | 0.083 0.061 DBMET00518 | DBMET00518 | |
| 0.035 | 0.312 | 0.224 | Multidrug resistance-associated protein 1 inhibitor | 0.224 0.006 DBMET00518 0.108 0.064 DBMET00599 | DBMET00518 | |
| 0.006 | 0.303 | 0.11 | NMDA 2 receptor antagonist | 0.11 0.027 DBMET00518 | DBMET00518 | |
| 0.012 | 0.316 | 0.618 | NMDA 2B receptor antagonist | 0.618 0.003 DBMET00518 | DBMET00518 | |
| 0.012 | 0.316 | 0.288 | Selectin antagonist | 0.259 0.008 DBMET00518 0.288 0.006 DBMET00599 | DBMET00599 | |
| 0.056 | 0.395 | 0.119 | DNA repair enzyme inhibitor | 0.119 0.075 DBMET00599 | DBMET00599 | |
| 0.045 | 0.393 | 0.195 | Platelet antagonist | 0.195 0.104 DBMET00599 | DBMET00599 | |
| 0.022 | 0.382 | 0.101 | DNA intercalator | 0.101 0.073 DBMET00599 | DBMET00599 | |
| 0.026 | 0.387 | 0.069 | Adenine nucleotide translocase inhibitor | 0.069 0.016 DBMET00518 | DBMET00518 | |
| 0.012 | 0.395 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 DBMET00518 0.028 0.015 DBMET00599 | DBMET00518 | |
| 0.015 | 0.654 | 0.191 | Dual specificity phosphatase inhibitor | 0.191 0.06 DBMET00518 | DBMET00518 | |
| 0.008 | 0.703 | 0.366 | Cholecystokinin B agonist | 0.366 0.003 DBMET00518 | DBMET00518 | |
| 0.01 | 0.719 | 0.183 | Dual specificity phosphatase 3 inhibitor | 0.183 0.071 DBMET00518 | DBMET00518 | |
| 0.005 | 0.846 | 0.312 | Anticoagulant | 0.312 0.026 DBMET00518 0.12 0.113 DBMET00599 | DBMET00518 | |
| 0.002 | 0.855 | 0.033 | Cholecystokinin B antagonist | 0.033 0.019 DBMET00518 | DBMET00518 | |
| 0.008 | 0.94 | 0.084 | Factor IXa inhibitor | 0.084 0.014 DBMET00518 | DBMET00518 | |
| 0.002 | 0.944 | 0.05 | Cholecystokinin A antagonist | 0.05 0.019 DBMET00518 | DBMET00518 | |
| 0.001 | 0.968 | 0.156 | Cholecystokinin agonist | 0.156 0.003 DBMET00518 | DBMET00518 | |
| 0.001 | 0.979 | 0.126 | Cholecystokinin A agonist | 0.126 0.003 DBMET00518 | DBMET00518 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |